The authors declare they have no competing financial interests.
In this systematic review we evaluated the evidence on the association between dioxin exposure and cardiovascular disease (CVD) mortality in humans.
We conducted a PubMed search in December 2007 and considered all English-language epidemiologic studies and their citations regarding dioxin exposure and CVD mortality. To focus on dioxins, we excluded cohorts that were either primarily exposed to polychlorinated biphenyls or from the leather and perfume industries, which include other cardiotoxic coexposures.
We included results from 12 cohorts in the review. Ten cohorts were occupationally exposed. We divided analyses according to two well-recognized criteria of epidemiologic study quality: the accuracy of the exposure assessment, and whether the exposed population was compared with an internal or an external (e.g., general population) reference group. Analyses using internal comparisons with accurate exposure assessments are the highest quality because they minimize both exposure misclassification and confounding due to workers being healthier than the general population (“healthy worker effect”). The studies in the highest-quality group found consistent and significant dose-related increases in ischemic heart disease (IHD) mortality and more modest associations with all-CVD mortality. Their primary limitation was a lack of adjustment for potential confounding by the major risk factors for CVD.
The results of this systematic review suggest that dioxin exposure is associated with mortality from both IHD and all CVD, although more strongly with the former. However, it is not possible to determine the potential bias, if any, from confounding by other risk factors for CVD.
Dioxins, a class of environmental pollutants resulting from the production and combustion of chlorinated compounds, have been shown to cause cardiovascular toxicity in animals (
The term “dioxin” refers to a diverse group of structurally related, environmentally persistent chemicals that exert toxic effects through a common pathway mediated by the aryl hydrocarbon receptor (
Although studies have demonstrated that the fetal mammalian heart is a sensitive target of TCDD-induced teratogenicity (
We found articles by searching PubMed (
We excluded studies with insufficient evidence of exposure to dioxin (e.g., ecologic studies, studies of Vietnam veterans not involved in herbicide spraying, or studies of pesticide applicators without information on which pesticides were used and whether dioxin contamination was possible). We also excluded studies whose primary exposure was to PCBs. Only 12 of 209 PCBs have dioxin-like activity, so exposure to non–dioxin-like PCBs would complicate the interpretation of any association of total PCBs with CVD.
Although dioxin exposure may occur during leather tanning and processing (
If several follow-up studies had been published for a cohort, we included only the most recent results. By necessity, we made an exception when applying this rule to the IARC multicenter cohort, which updated and pooled the results of 36 individual cohorts (
Eleven cohorts (
Although quantitative dioxin exposure profiles for each cohort were not available because limited biological measurements were performed, broad exposure categorizations are possible. The workers in the 10 occupational cohorts were primarily exposed to PCDDs through the production and/or application of phenoxy acid herbicides and chlorophenols (
We grouped study results according to two well-recognized criteria of study design quality. The first criterion was whether mortality among the exposed participants was compared with an internal or an external reference group. External comparisons used standardized mortality ratios (SMRs) to compare the number of deaths observed in the exposed group (e.g., dioxin-exposed factory workers) with the number of deaths expected in the general population, standardized for age and sex. The primary limitation of external comparisons is that whenever the exposed group is an employed population, associations between exposure and CVD mortality will be biased downward (generally below the null) because workers are healthier on average than the general population (
The second criterion we used to evaluate studies in this review was exposure assessment quality. Many studies had little information on exposure level and therefore considered all members of the exposed group to be equally exposed. Because of these crude exposure estimates, the exposed groups may have contained individuals with low or no actual exposure. This nondifferential misclassification would tend to dilute any associations between exposure and CVD mortality, biasing the associations downward. In contrast, some studies were able to conduct more detailed exposure assessments, using exposure measures that varied in complexity from dichotomous yes/no exposure among workers (IARC), to septiles of cumulative exposure [National Institute for Occupational Safety and Health (NIOSH)]. Additional details on these studies’ personal exposure assessments can be found in the original articles (
Four studies conducted external comparisons but stratified their SMRs by detailed exposure level (
In the Seveso study,
The IHD SMRs (95% CIs) for the IARC and NIOSH studies from lowest to highest exposure using the same categories as shown in
For all-CVD mortality, the dose-related increases in mortality were less clear than for IHD (
A major concern in all the reviewed studies was potential confounding by the major risk factors for CVD (e.g., diet, smoking, physical activity). If these risk factors were strongly associated with dioxin exposure, they could confound the association between dioxins and CVD, biasing it either upward or downward. Of the studies in
The Hamburg study (
The present review synthesizes the epidemiologic studies of dioxin and CVD mortality and advances our understanding by considering in detail the studies according to their quality. Studies using external comparisons and crude exposure estimates found no association between dioxin exposure and increased risk of IHD or all-CVD mortality, but this may be due to healthy worker effect bias (
The Seveso study (
The major limitation of these epidemiologic studies is the lack of adjustment for other major risk factors for CVD (including smoking, lack of physical activity, poor diet, and alcohol consumption). Only age was consistently adjusted for. The Ranch Hand (
Some recent cross-sectional studies of dioxin exposure and CVD morbidity have found associations that persisted after more thorough adjustment for confounding (
The associations between dioxin exposure and increased risk of cardiovascular mortality were in study populations with dioxin levels substantially higher than U.S. general population levels (
The RRs from internal comparisons across the various studies are similar, even though the mean exposure levels differ. However, in each case the highest exposed category consisted of individuals with estimated exposures of comparable magnitude (
Another weakness of the reviewed mortality studies is the difficulty of accurately retrospectively assessing personal exposure. However, this exposure misclassification is likely to be nondifferential with respect to CVD mortality, which would tend to decrease the observed associations in the highest exposure category (
Most studies reported results only for TCDD, and not total TEQ, which is considered more biologically relevant. In addition, dioxin exposure was usually accompanied by coexposure to other contaminants, whose precise composition varied within occupational settings, and between occupational and environmental settings. It is a limitation of epidemiologic studies that separating out the effect of any one specific contaminant is difficult, especially given the possibility of synergism or antagonism. The primary occupational coexposure was to chlorophenols and their derivatives, but the available toxicologic studies of chlorophenols do not suggest that they have toxic effects on the cardiovascular system [
Our findings do not directly address the risks of dioxin exposure for females because none of the internal comparison studies included substantial numbers of women. In a general population morbidity study,
The downward bias of the SMRs of occupational studies due to the healthy worker effect complicates their interpretation. This bias is illustrated by the substantially stronger associations found using internal comparisons than using SMRs in the IARC (
Although information on the mortality status of the participants was available at the time of the retrospective exposure assessment, this was unlikely to influence the estimation process in a way that might induce a relationship between the estimated dioxin exposure and CVD mortality because the
These studies were also limited by their reliance on mortality and death certificate diagnoses. However, CVD mortality is likely to be diagnosed relatively accurately, and any errors would affect the precision but not the validity of the results. Virtually identical
The IARC internal comparison results at least partially include the results from three of the other internal comparison studies (
The results of this systematic review suggest that dioxin exposure is associated with increased risk of mortality from both IHD and all CVD, although more strongly with the former. Although biological plausibility is provided by animal studies, uncontrolled confounding by other risk factors for CVD cannot be ruled out as a contributor to the association.
We hope our results will stimulate further evaluation of CVD incidence and mortality in dioxin-exposed cohorts, especially using internal comparisons with detailed exposure assessments, and careful control for confounding. Future studies in both animals and humans should assess whether cardiovascular effects are present at environmentally relevant doses. Of additional interest would be analysis of whether the association between dioxin exposure and all CVD persists when IHD cases are excluded, as well as a pooled or meta-analysis of the internal comparison results in order to obtain a dose–response curve for dioxin and CVD.
We thank G. Rice and M. DeVito of the U.S. EPA for thoughtful comments on the manuscript.
This report has been reviewed by the U.S. EPA’s Office of Research and Development and approved for publication. Approval does not signify that the contents necessarily reflect the views and policies of the agency, nor does mention of trade names or commercial products constitute endorsement or recommendation for use.
O.H. is supported by National Institute for Occupational Safety and Health training grant T42 OH008416-04.
Flow diagram of study selection process using PubMed.
RRs (95% CIs) for IHD mortality from internal comparisons, by quantiles of dioxin exposure within each study. The exposure categories are not necessarily equivalent across studies (
RRs (95% CIs) for all-CVD mortality from internal comparisons, by quantiles of dioxin exposure within each study. The exposure categories are not necessarily equivalent across studies (
RRs (95% CIs) for mortality from IHD and all CVD from both internal and external comparisons with crude exposure assessments, in dioxin-exposed cohorts.
| Comparison type/cohort | No. | IHD | All CVD | Reference |
|---|---|---|---|---|
| External | ||||
| Canadian sawmill | 23,829 | NA | 0.74 (0.71–0.76) | |
| Seveso | 6,745 | 1.00 (0.8–1.2) | 1.00 (0.8–1.1) | |
| NIOSH | 5,132 | 1.09 (1.00–1.20) | NA | |
| Finnish sprayers | 1,909 | 0.94 (0.80–1.10) | NA | |
| Yucheng | 1,823 | NA | 1.00 (0.8–1.3) | |
| Hamburg | 1,177 | 0.97 (0.77–1.22) | 1.06 (0.90–1.24) | |
| New Zealand | ||||
| Production | 813 | 1.04 (0.74–1.43) | 0.96 (0.72–1.27) | |
| Sprayers | 699 | 0.49 (0.31–0.75) | 0.52 (0.36–0.73) | |
| Dutch | 549 | 1.20 (0.8–1.6) | 1.00 (0.8–1.4) | |
| BASF | 243 | 0.70 (0.4–1.1) | 0.80 (0.6–1.2) | |
| Internal | ||||
| Ranch Hand | 20,340 | NA | 1.30 (1.0–1.6) | |
| Army Chemical Corps | 5,609 | NA | 1.06 (0.62–1.82) | |
NA, data not available.
Using an alternate method of estimating person-time, the SMR for all CVD was 1.14 (1.10–1.18).
RRs (95% CIs) for mortality from IHD and all CVD from internal comparisons, by dioxin exposure level.
| Study | No. | IHD | All CVD |
|---|---|---|---|
| IARC ( | 21,384 | ||
| No | 7,553 | 1.00 (—) | 1.00 (—) |
| Yes | 13,831 | 1.67 (1.23–2.26) | 1.51 (1.17–1.96) |
| NIOSH | 3,538 | ||
| 0 to < 19 | 505 | 1.00 (—) | NA |
| 19 to < 139 | 505 | 1.23 (0.75–2.00) | NA |
| 139 to < 581 | 505 | 1.34 (0.83–2.18) | NA |
| 581 to < 1,650 | 505 | 1.30 (0.79–2.13) | NA |
| 1,650 to < 5,740 | 505 | 1.39 (0.86–2.24) | NA |
| 5,740 to < 20,200 | 505 | 1.57 (0.96–2.56) | NA |
| ≥20,200 | 505 | 1.75 (1.07–2.87) | NA |
| Trend | |||
| Ranch Hand | 2,452 | ||
| Comparison | 1,436 | NA | 1.00 (—) |
| Background | 442 | NA | 0.80 (0.4–1.8) |
| Low (32.2–117.4) | 287 | NA | 1.80 (0.9–3.5) |
| High (117.9–4221.9) | 287 | NA | 1.50 (0.7–3.3) |
| Trend | |||
| Hamburg | 1,177 | ||
| 1.19–39.5 | 471 | 1.00 (—) | 1.00 (—) |
| 39.6–98.9 | 235 | 0.85 (0.41–1.75) | 1.34 (0.85–2.13) |
| 99.0–278.5 | 235 | 0.86 (0.41–1.83) | 1.18 (0.71–1.95) |
| 278.6–545.2 | 118 | 1.31 (0.57–3.00) | 1.21 (0.66–2.25) |
| 545.3–4361.9 | 118 | 1.89 (0.79–4.51) | 1.40 (0.71–2.76) |
| Trend | Trend | ||
| Dutch | 1,031 | ||
| Low (7.1) | 530 | 1.00 (—) | 1.00 (—) |
| Medium (7.7–124.1) | 259 | 1.50 (0.7–3.6) | 1.50 (0.8–2.8) |
| High (124.2–7307.5) | 242 | 2.30 (1.0–5.0) | 1.50 (0.8–2.9) |
| BASF | 243 | ||
| 1 μg/kg increase | NA | 0.93 (0.70–1.24) |
Abbreviations: HCD, higher chlorinated dioxins; NA, data not available.
The number for each exposure group was estimated by dividing the sample into septiles, as done by
The serum dioxin levels were extrapolated back to the end of service in Vietnam. No extrapolated dioxin levels were presented for the comparison or background categories.
The number for each exposure group was estimated by combining the two lowest quintiles and halving the highest quintile, as done by
The serum dioxin levels were extrapolated back to the end of occupational exposure.
This study presented the RR for all CVD only for a 1-μg/kg increase in estimated TCDD dose.